Trial intelligence / Profile preview

Comparison of efficacy of Medikinet retard vs Concerta in children with ADHD

2005-003295-38Phase 4Completed

Sponsor
Medice
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Medice. Primary endpoint: SKAMP-D score during first three school lessons. Started Nov 2005; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2005-003295-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003295-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call